Sterigenics International LLC, a provider of contract sterilization, gamma technologies and medical isotopes, and a portfolio company of Warburg Pincus and GTCR, announced expansion at their Wiesbaden, Germany location. The expansion will increase ethylene oxide processing capacity by 20 percent and allow for additional future capacity expansion of an additional 20 percent. Construction will be completed by Q1 2017.
“This expansion represents the continued execution of our growth strategy,” said Michael Mulhern, CEO of Sterigenics International. “We will continue to pursue high impact acquisitions such as the recent addition of Nelson Laboratories, while at the same time, expanding our existing capabilities.”
“The Wiesbaden expansion is in response to growing demand for ethylene oxide processing in Western Europe,” said Philip Macnabb, President of Sterigenics International. “Wiesbaden has always been a premier facility and this expansion will not only address our short term need, but allow for growth for the future as well. This first part of this expansion will increase capabilities across all phases of the ethylene oxide processing from pre-conditioning, to chamber space and aeration.”
Opened in 2006, Sterigenics Wiesbaden provides routine ethylene oxide processing, rapid turnaround STAT service, process validation and laboratory testing.